AbbVie, Gilead Sciences, Pfizer, and Roche are among the companies that must cut a check to the U.S. government. Those companies have Medicare-covered medicines whose prices rose faster than inflation and according to a…
Continue Reading
Seagen, the biotech company Pfizer is buying for $43 billion, is considered a pioneer in the class of cancer drugs called antibody drug conjugates. But the first ADC to reach the market wasn’t a…
Continue Reading
Novo Nordisk is slashing prices of several insulin products by up to 75% amid growing political scrutiny on the prices of these older but still expensive diabetes medicines. The announcement Tuesday comes two weeks…
Continue Reading
California-based Rune Labs, a precision neurology software and data platform company, is partnering with BlueRock Therapeutics, a clinical-stage biopharmaceutical company and subsidiary of Bayer AG, to aid in studying Parkinson’s disease.BlueRock will utilize Rune…
Continue Reading
In todays fast-paced world, it is easy to miss out on important information, especially if you are trying to keep up with a lot of different sources. That is where the daily digest comes in – it is a tool that compiles all the posts created on the previous day, providing you with a convenient […]
Continue Reading
Life sciences organizations have access to more data than ever before. When they leverage that existing data during their research and development (R&D) process, organizations can drive more efficient drug development.
Innovation and regulatory approval…
What You Should Know:– Sanofi has agreed to acquire Provention Bio, Inc., a U.S.-based, publicly traded biopharmaceutical company focused on intercepting and preventing immune-mediated diseases including type 1 diabetes (T1D), for $25.00 per share in cash, representing an equity…
Continue Reading
More than a decade after the Affordable Care Act was signed into law, U.S. healthcare costs continue to spiral at rates unseen in the rest of the developed world.
But while healthcare costs overall are…
What You Should Know:– Medidata announced that Allucent, a contract research organization (CRO) bringing innovation to biopharma companies, is expanding the global use of Medidata’s Clinical Cloud to advance its end-to-end clinical trial operations offering. – The agreement expands Allucent’s existing utilization of Medidata technologies. These include Rave EDC, eCOA, RTSM, and Rave Imaging, in support…
Continue Reading
Epstein-Barr is among the most common viruses, but no vaccines are available to prevent its infection. Merck is joining the pursuit for a vaccine by striking a deal with Opko Health, paying $50 million…
Continue Reading
